Third quarter 2018 results

Highlights

Sanofi Q3 2018 Performance Confirms Return to Growth

Third quarter 2018 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.

With the performance we delivered in the third-quarter, Sanofi has returned to growth. We have delivered on our promise to shareholders, while bringing important new medicines and treatments to patients around the world

Olivier Brandicourt

Chief Executive Officer

Streaming

Downloads

Download the audio mp3 file

Presentation

Clinical trials appendix

Press Release - October 31, 2018: Sanofi Q3 2018 Performance Confirms Return to Growth

Q3 2018 income statements

Q3 2018 net sales by GBU, franchise, geographic region and product

Download infographic